| ID | Sequence | Length | GC content |
|---|---|---|---|
| GAACGGCUUCGCGAGUUGGGGCAGCUCCUCGCGCUCGGCCCUGCUCGGC… | 5904 nt | 0.5373 | |
| GUGUUUACAGUCACCAGCAGGCUGCGUAAAGAAGUGGCCCAGUGAGACA… | 5625 nt | 0.5170 | |
| GAACGGCUUCGCGAGUUGGGGCAGCUCCUCGCGCUCGGCCCUGCUCGGC… | 5778 nt | 0.5381 | |
| GUGAAGCGCACACCGACGGGGACGAGAGCGCAGAGGAUGGCGCUUUUAG… | 5583 nt | 0.5207 |
This gene encodes a member of the RGS (regulator of G protein signaling) family of proteins, which are defined by the presence of a RGS domain that confers the GTPase-activating activity of these proteins toward certain G alpha subunits. This protein also belongs to a subfamily of RGS proteins characterized by the presence of DEP and GGL domains, the latter a G beta 5-interacting domain. The RGS proteins negatively regulate G protein signaling, and may modulate neuronal, cardiovascular, lymphocytic activities, and cancer risk. Many alternatively spliced transcript variants encoding different isoforms with long or short N-terminal domains, complete or incomplete GGL domains, and distinct C-terminal domains, have been described for this gene, however, the full-length nature of some of these variants is not known.[provided by RefSeq, Mar 2011]
A study in human postmortem cerebellar tissue demonstrated that the RGS6 was analyzed via qRT-PCR as a candidate gene from a whole-genome microarray, which identified significant gene expression changes following traumatic frontal cortex injury [Schober et al. DOI:10.1007/s00414-014-1129-3]. A review of long noncoding RNAs in cardiovascular diseases notes that the RGS6 is hypothesized as a biomarker for Tetralogy of Fallot in humans [Yeh et al. DOI:10.1186/s12929-020-00647-w].